Nortis is a recognized leader in the organ-on-chip field. Founded by former UW faculty Nortis’ ParVivo Organ-on-Chip platform has been commercially available since 2015. Nortis also provides services in organ model and assay development using the ParVivo platform.
Nortis' vision is to facilitate groundbreaking scientific discoveries and accelerate their impact on improving human health, safety, and quality of life.
Nortis is dedicated to developing a new generation of in vitro systems that advance the discovery of novel therapies and reduce the timeline and costs associated with their translation into the clinic.